TONIX PHARMACEUTICALS HOLDING CORP. Available-for-sale Securities, Gross Unrealized Loss
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Available-for-sale Securities, Gross Unrealized Loss of $27.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2016-03-03
- TONIX PHARMACEUTICALS HOLDING CORP. available-for-sale securities, gross unrealized loss for fiscal 2015 was $27.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. available-for-sale securities, gross unrealized loss for fiscal 2014 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. available-for-sale securities, gross unrealized loss for fiscal 2013 was $0.00.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|
| 2015-12-31 | $27.00K 10-K · filed 2016-03-03 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-03 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |